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Objective: The objective is to provide an evidence-based compendium of allergenic and irritant agents that are
known to cause occupational asthma in order to improve diagnostics and disease management.
Methods: Two previously published reviews from our group utilized database searches to identify studies which
were then rated according to the Scottish Intercollegiate Guideline Network (SIGN) grading system. The evidence
level for each causative agent or worksite was graded using the Royal College of General Practitioners (RCGP)
three-star system.
Results: Approximately 3,000 relevant papers were identified, which covered 372 different causes of allergic and
184 different causes of irritant occupational asthma. The highest level achieved using the SIGN grading system was
2++, indicating a high quality study with a very low risk of confounding or bias and a high probability of a causal
relationship. Using the modified RCGP three-star grading system, the strongest evidence of association with an
individual agent or worksite ('***') was found for exposure to laboratory animals. Associations with moderate
evidence level (‘**’) were obtained for a) the allergenic agents or worksites: alpha-amylase from Aspergillus oryzae,
various enzymes from Bacillus subtilis, papain, bakeries, western red cedar, latex, psyllium, storage mites, rat, carmine,
egg proteins, Atlantic salmon, fishmeal, Norway lobster, prawn, snow crab, seafood, trout and turbot, reactive dyes,
b) the irritant agents or worksites: benzene-1,2,4-tricarboxylic acid, 1,2- anhydride [trimellitic anhydride], chlorine,
cobalt, cement, environmental tobacco smoke, grain, welding fumes, construction work, swine confinement, World
Trade Center disaster 2001, and c) agents or worksites causing allergic as well as irritant occupational asthma,
included farming, poultry confinement, various isocyanates and platinum salts. A low evidence level (RCGP) was
obtained for 84 agents or worksites (42 from each group), providing a total of 141 conditions with a low, moderate
or strong evidence level.
Conclusion: This work comprises the largest compendium and evaluation of agents and worksites causing allergic
or irritant occupational asthma from the literature assessed in an evidence-based manner.Introduction
Occupational asthma is a disease characterized by variable
airflow limitation and/or hyper-responsiveness associated
with inflammation which is attributable to causes and
conditions in a particular occupational environment and
not to stimuli encountered outside the workplace [1].
Occupational asthma involves IgE-mediated asthma
after a latency period, irritant asthma with or without
a latency period, including reactive airways dysfunction
syndrome (RADS), resulting from high exposure, and
asthma due to specific occupational agents withCorrespondence: xaver.baur@charite.de
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reproduction in any medium, provided the orunknown pathomechanisms that may also show a latency
period [2,3] (Figure 1). Occupational asthma needs to be
differentiated from work-aggravated asthma, which is
characterized by a worsening of pre-existing asthma or
increase in airway resistance, asthma medications or
frequency and/or severity of asthma attacks arising
from causes and conditions attributable to a particular
occupational environment and not to stimuli encountered
outside the workplace. These workers have a concurrent
history of asthma that was not induced by exposure in the
workplace. Aggravation is typically due to an occupational
irritant (e.g. non-sensitizing fumes) [4]. There are
also workers with pre-existing asthma who, after a
latent interval, have a worsening of their pre-existings is an Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Subgroups of occupational asthma.
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agents which cause IgE-mediated allergies. No detailed
studies or valid statistics relevant to work-aggravated
asthma are available. The current study focuses on the
identification of causes of occupational asthma and is
based on two recently published reviews, evaluating
occupational allergens [5] and irritants [6] in an evidence-
based manner.Methods
Appropriate terms were used to search Medline via PubMed
(www.ncbi.nlm.nih.gov/mesh). The combination of
medical subject headings (MeSH) used were as followsOccupational asthma due to allergens
("1"[PDAT] : "2011/08/01"[PDAT]) AND ((((((((((("Signs
and Symptoms, Respiratory"[MeSH] OR "Occupational
Diseases"[MeSH]) OR "Allergy and Immunology"[Majr])
OR "Respiratory Function Tests"[MeSH]) OR "Bronchial
Hyperreactivity"[MeSH]) OR "Airway Obstruction"[MeSH])
OR "Respiratory Hypersensitivity"[MeSH]) OR "Lung
Diseases, Obstructive"[MeSH]) OR "Asthma"[MeSH]) OR
"Asthma"[Mesh]) OR "Occupational Exposure"[MeSH])
AND "ALLERGEN"[MeSH]) AND ("humans"[MeSH]
AND (English[lang] OR French[lang] OR German[lang])
AND "adult"[MeSH])Occupational asthma due to irritants
This procedure differed from the aforementioned with "Re-
spiratory Hypersensitivity"[MeSH]), "ALLERGEN"[MeSH])
replaced by "Asthma/chemically induced"[MeSH], "Lung
Diseases, Obstructive/*chemically induced"[MeSH], "Occu-
pational Diseases/chemically induced"[MeSH].The searches were completed and included publications
up until August 2011 (allergens) and to the end of June
2012 (irritants).
References collated in seminal systematic reviews or
overviews of causes of work-related asthma were also
included and the results from both approaches were
combined.
The occupational diseases statistics based either on
statutory surveillance or registration systems: SWORD
1994–1997 [7-9], SHIELD 1993 [10], SORDSA 2001 [11],
SENSOR [12] and Dokumentation der Berufskrankheiten
2007 (BK-DOK) [13], were also included.
A list of agents denoted as “may cause sensitization by
inhalation“ by the phrase H334 (until 2011 R42), and as
“may cause respiratory irritation” by the phrase H 335
(until 2011 R37), respectively, according to regulations
of the European Parliament [14] was also considered.
All studies were assessed for potential biases (selection,
confounding, information bias), in particular the sources
of bias and bias minimisation strategies in either the
design or analysis phase, specific to each study design.
The methodological quality of each selected publication
was assessed by an experienced reviewer and discussed
with the senior physician of the occupational unit who
independently assessed the publications, before rating
each according to the modified Scottish Intercollegiate
Guidelines Network (SIGN) classification [15]. The slightly
extended RCGP (Royal College of General Practitioners
1995) three-star system was used to grade the evidence
for each agent on the basis of all available publications.
The three-star system considers quality and quantity of all
studies as well as consistency of reported findings. Our
extensions comprised: [ ] indicated down-grading due to
lower quality of clinical investigations, i.e., due to missing
objective parameters such as lung-function data; further,
(*) indicated up-grading from '-' due to at least 5 reported
asthma cases without contradictory findings (see Table 1).
For further methodological details of the selection criteria,
data extraction and synthesis, quality assessment of




The database search resulted in 2,315 potentially relevant
publications referring to allergen-induced asthma and 863
referring to irritant-induced asthma. After exclusion of
non-occupational cases, a total of 865 allergen-induced
and 474 irritant-induced asthma studies remained. These
publications refer to 372 individual allergenic and 184
irritant agents or worksites that were identified to cause
occupational asthma, of which 36 were listed as both
allergens and irritants, leaving a final total of 520 different
causes of occupational asthma. For 78 allergens and 71
Table 1 The modified Royal College of General Practitioners (RCGP) three-star system of the British Occupational
Health Research Foundation
*** Strong evidence – provided by generally consistent findings in multiple, high quality, scientific studies.
** Moderate evidence – provided by generally consistent findings in fewer, smaller or lower quality, scientific studies.
*[*] Moderate evidence – provided by generally consistent findings in fewer, smaller or lower quality, scientific studies,
based on questionnaire-conducted studies or other weak evidence (i.e. clinical weakness due to absence of LFT, sPFT, SIC)
* Limited or contradictory evidence – provided by one scientific study (analytic) or inconsistent findings in multiple scientific studies.
[*] Limited or contradictory evidence – provided by one scientific study (analytic) or inconsistent findings in multiple scientific studies,
based on questionnaires or other weak evidence (i.e. clinical weakness due to absence of LFT, sPFT, SIC)
(*) Very limited or contradictory evidence – provided by at least three case reports, one case series, one non-analytic study or one
occupational disease statistical study with at least five asthma cases
- No scientific evidence – based on clinical studies, theoretical considerations and/or clinical consensus
(BOHRF, [16]) Applied modifications are underlined.
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level of at least ‘*’ in the RCGP grading system was found.
Strength of evidence per agent or worksite (Table 3)
Allergens
Strong evidence, i.e. three stars ‘***’ was achieved from
exposure to laboratory animals. For 18 agents or worksites,
the strength of evidence corresponded to two stars ’**’.
Moderate evidence, provided by generally consistent
findings in fewer, smaller or lower quality scientific
studies with clinical weakness ‘*[*]’ was found for 17
agents. Limited or contradictory evidence ‘*’, was identified
for 18 agents. For 24 agents, down-grading to '[*]' was
necessary because of absent objective data.
The majority of agents were investigated in non-analytical
studies. Thus, the strength of evidence ranged from very
limited or contradictory evidence ‘(*)’ (19 agents or
worksites) to no scientific evidence ‘-‘ (275 agents or
worksites).
Irritants
For 17 (mixed) agents or worksites, two stars ‘**’ were
achieved and none reached a higher level. Low to moderate
scientific evidence, i.e. ‘*[*]’ , was found for 12 agents.
Limited or contradictory evidence.’*’ was identified for
39 agents or worksites and a further three agents were
down-graded because of inadequate methodologicalTable 2 Review of the literature on allergens or irritants
causing occupational asthma
Findings Allergens Irritants
Potentially relevant publications and considered 2,315 863
Publications which were found to be useful and
were included
865 474
Different potential causative agent or workplaces
identified
372 184
Evidence-based causative agents or workplaces* 78 71
*Overlap of 12 agents resulting of 137 different causative allergenic and/or
irritant causative agents or workplaces.aspects. "Very limited or contradictory evidence” was
obtained 29 times and no scientific evidence 94 times.
Interestingly, our literature search identified a group of
15 irritant agents or worksites that were found to cause
occupational asthma and/or COPD, namely: ammonia,
cement dust, chlorine, cleaning agents, mustard gas, diesel
exhaust, environmental tobacco smoke, isocyanates, smoke
from fires, sulfur dioxide, construction work, swine
confinement, farming, foundry, metallurgic industry.
Agents behaving as both allergen and irritant
36 agents or worksites were found to cause allergic as
well as irritant occupational asthma; for twelve of them
evidence – mainly at a low level – was available (Table 4).
With the exception of anhydrides and isocyanates there
was no close relationship with the respective H334 and
H335 phrases, respectively.
Discussion
As reported by various authors ([17-19]), about 15% of
adult asthma cases are caused by occupational agents,
whether IgE-mediated or irritant occupational asthma or
occupational asthma due to unknown pathomechanism.
Irritant asthma may arise from high dose, moderate or
even low dose exposure with the clinical pictures of RADS
and not-so-sudden-onset irritant asthma. The latter, as well
as occupational asthma of unknown pathomechanism,
mostly show a latency period from the beginning of
causative exposure until the appearance of symptoms, which
makes these indistinguishable from allergic asthma [20].
Previous reports and reviews have accumulated narrative
and experimental evidence for about 300 causative agents,
which are often divided into high or low molecular weight
groups ([21-28]). High molecular weight agents typically
induce asthma through an IgE-mediated mechanism while
the pathomechanism of low molecular weight agents is
mostly airway irritation or unknown.
Quirce and Sastre recently summarised the newer
causative agents published between 2009 and 2011 [22].





of agents or worksites
Agent or worksite allergen Agent or worksite irritant
[Synonym] (CAS)
*** 1/0 Co-exposure to various lab animals -
** 18/12 Alpha-amylase from Aspergillus oryzae; various enzymes from
Bacillus subtilis; papain; bakery (flour; amylase; storage mites);
western red cedar; latex; Psyllium; farming (animals, cereal,
hay, straw and storage mites); storage mites; rats; carmine;
egg proteins; Atlantic salmon; fishmeal; Norway lobster;
prawns; snow crabs; seafood; trout and turbot; reactive
dyes; toluene diisocyanates (TDI); platinum salts;
Benzene-1,2,4-tricarboxylic acid; 1,2- anhydride [trimellitic anhydride] (552-30-7);
chlorine (7782-50-5); cobalt (7440-48-4); various isocyanates, isocyanurate (HDI,
MDI, TDI), phenylmethane diisocyanate [MDI] (5873-54-1), toluene diisocyanate,
TDI 2,4 (584-84-9),TDI 2,6: (91-08-7); platinum salts (7440-06-4); cement [78];
environmental tobacco smoke; grain [78]; welding fumes; construction work
(dust, agent unspecified); farming, animals (pig, beef/veal, dairy, poultry); swine
confinement; World Trade Center disaster 2001
*[*] 17/39 Detergent enzymes, soybean (husks, flour); paprika; tea dust;
tobacco; Aspergillus niger; cows; predatory mites; spider mites;
opiates; methylene diphenyl diisocyanate (MDI), phthalic
anhydrides; various isocyanates
Ceramic production [78]; phthalic anhydride (85-44-9); glutaraldehyde
[glutaral] (11-30-8); sulfur dioxide (7446-09-5); cotton (dust; raw) CNT 750;
potroom aluminum smelting; farming (various); foundry; smoke (fires,
pyrolysis products); pesticides (unspecified); cleaning agents (unspecified);
health care workers;
* 18/39 Eastern white cedar; various flowers; guar gum; poppy; rose
(Rosa rugosa); senna; ispaghula husks; sunflower pollen; trypsin;
various woods (abies, chestnut, douglas, framire, mansonia, oak,
obeche, walnut, white poplar); weeping fig; nonbiting midges;
hexahydrophthalic anhydride; hexamethylene diisocyanate (HDI);
methyl tetrahydrophthalic anhydride (MTHPA); persulfate salts;
polyfunctional aziridine
Acetic acid (64-19-7); sulfuric acid (7664-93-9); metacrylates; loctide
(53858-53-0); aluminum salts [aluminum fluoride] (7724-18-1); aluminum
sulfate: (10043-01-3); ammonia (7664-41-7); various anhydrides;
tetrachlorophthalic anhydride (117-08-8); azobisformamide (123-77-3);
cadmium (fumes) (7440-43-9); carbon black dust (1333-86-4); ethylenediamine
(107-15-3); formaldehyde (gas, dust) (50-00-0); hexamethylene-tetramine
(100-97-0); methyl isocyanate [MIC] (624-83-9); naphthylene diisocyanate
(3173-72-6); polymethylene polyphenyl isocyanate (9016-87-9);
N-methylmorpholine (09-02-4); ozone (gassings) (10028-15-6); paraquat
(4685-14-7); diammonium peroxodisulfate (7727-54-0); phenylglycine acid
chloride (39478-47-2); piperazine dihydrochloride (142-64-3); polyvinyl chloride
(fume) (9002-86-2); rosin core solder; thermal decomposition (8050-09-7);
vanadium (7440-62-2) + divanadium pentoxide (1314-62-1); cleaning agents
(not specified); green coffee [78]; diesel exhaust; endotoxin; oil (spill); paint
(fumes); pesticides (unspecified); reactive dyes; refractory ceramic fibers [RCF];
smoke (fires, pyrolysis products; oil fire and dust storm); soldering flux; solvents
(unspecified); healthcare workers; poultry confinement; slaughter house; metal
industry workers
[*] 24/3 Alternaria; bromelain from Ananas comosus; cellulase from
Trichoderma viride; lactase from aspergillus; various enzymes;
chrysanthemums; castor beans; madagascar jasmine; pine; flowers;
budgerigar; flour moth; house dust mites; mouse; poultry; red soft
corals; screw-worm fly; shrimp; various birds; cephalosporine;
penicillins; phenylglycine; acid chloride; trimellitic anhydride
Nitrogen chloride (10025-85-1); polyamines; aliphatic; potassium persulfate
(7727-21-1) and ammonium peroxydisulfate (7727-54-0); grain rice [78]
(*) 19/29 Aspergillus enzymes; cellulase from Trichoderma reesei; pancreatin;
proteolytic enzymes; asparagus; Boletus edulis; carnation; garlic dust;
rye flour; gum arabic; iroko; various woods; African maple; black bat;
mealworm; poultry mites; tetrachlorophtalic anhydride; chloramine
T; chromium and nickel
Acids not specified; hydrochloric acids (7647-01-0); alkyl cyanoacrylates;
3-amino-5-mercapto-1;2,4-triazole l(16691-43-3); aziridine, polyfunctional [78]
(64265-57-2); chloramine T (powder dust) (7080-50-4); chromate (not specified);
3-(diamino-amino)propylamine (109-55-7); dichlorodiethyl sulfide (505-60-2);
2-diethylaminoethanol (100-37-8); diinitrogen tetraoxide (10544-72-6);
hexamethylene diisocyanate [HDI], plus isodurane diisocyanate (822-06-0);
HDI biuret plus (4035-89-6); anhydrous nickel sulfate (7786-81-4); hexahydrate
(10101-97-0); paraphenylenediamine (106-50-3); persulfate (not specified);



















Table 3 Strength of evidence for occupational asthma-caused by allergens, irritants or worksites according to the modified RCGP three-star system (Continued)
potassium aluminum tetrafluoride (14484-69-6); sodium iso-nonanoyl
oxybenzene sulfonate [SINOS] (123354-92-7); sodium metabisulfite (7681-57-4);
styrene monomer (100-42-5); chlorofluorocarbons (degradation products);
hairdressing chemicals; lubricants (unspecified); paper dust A111; aliphatic
polyamines; polyester; powder paints; smoke (biomass, indoor)
- 275/94 Unlisted as no corroborating scientific evidence presented Unlisted as no corroborating scientific evidence presented
CAS, Chemical abstracts service.



















Table 4 36 agents identified as occupational asthma-inducing allergens as well as irritants (see column 1 of Table 3 for
full range of evidence levels)
Agent Evidence level as allergen Evidence level as irritant H334 H335
Aluminium/potroom - *
2-Ethanolamine - - x
Aminoethylethanolamine - - x
Anhydrides, various - * x
Anhydrides, hexahydrophthalic * - x
Anhydrides, maleic - - x
Anhydrides, methyltetrahydrophththalic - - x
Anhydrides, phthalic anhydride *[*] *[*] x x
Anhydrides, tetrachlorophthalic anhydride (*) * x
Azobisformamide - * x
Captafol - -
Chloramine T (*) (*) x
Chlorohexidine - - x x
Cobalt - **
Diethanolamine - -
Formaldehyde - * x
Glutaraldehyde - *[*] x
Hexachlorphene - -
Isocyanate, diphenylmethane diisocyanate (MDI) *[*] ** x x
Isocyanate, hexamethylene diisocyanate (HDI) * (*) x x
Isocyanate, 1,5-naphthylene diisocyanate (NDI) - (*) x x
Isocyanate, toluene diisocyanate (TDI) ** ** x x
Isocyanate, triglycidil isocyanurate - -
Paraphenylenediamine - (*)
Persulfate * (*) x x
Piperazine dihydrochloride - * x
Platinum salts ** **
Tetrachloroisophthalonitrile - - x
Tributyl tin oxide - -
Vanadium - *
Zinc - -
Green coffee (dust) *[*] *
Reactive dye ** *
Welding fumes - **
Farming ** *[*]
Poultry confinement [*] *(*)
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http://www.occup-med.com/content/8/1/15A continuously updated classification of allergenic or
irritant occupational asthma agents has been provided
by the American Conference of Governmental Industrial
Hygienists (ACGIH) [29], the German MAK commission
[30], the Health and Safety Executive [31] and the European
Community [14]. At present, the new international labelling
of working materials hazardous to health (GHS; EU: CLP),
which includes airway allergenic and iritative agents, hasbeen put in force and has replaced the hitherto R and S
notes with hazard (H) and precautionary statements (P) as
well as by new hazard pictograms (European Parliament
[14], United Nations [32]).
These reviews and classifications all lack an evidence-
based evaluation of identified agents in the clinical
literature. An evidence-based evaluation of the literature
is of particular importance for case management and
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work was to provide a scientific compendium of practical
relevance, exhaustively listing the agents and worksites
known to cause occupational asthma.
From more than 3,000 publications, 1,339 were retrieved
from our Medline/PubMed and additional database
searches, which refer to 372 individual agents or worksites
that have been identified to cause allergic occupational
asthma and 184 individual agents or worksites known to
cause irritant occupational asthma. Of these 520 individual
agents or worksites, 36 occurred in more than one category.
Evidence for causing occupational asthma was found for
78 allergens and for 71 irritants, respectively, with 8
eliciting an allergic as well as an irritative pathomechanism,
establishing 141 in total.
The evidence levels for causing occupational asthma
of many of the listed agents or worksites are moderate to
low since only about a quarter of the identified studies
were analytical, primarily because randomised controlled
trials are not considered ethical when studying the exposure
effects of harmful agents. Therefore, high quality studies
are largely absent and the few available studies are
frequently small in number of workers studied.
The vast majority are surveys, case series or case
reports with evidence levels rated very low. The common
diagnostic procedure for occupational asthma in clinical
settings is a stepwise approach, including questionnaires
about asthma-specific symptoms as well as respiratory
and allergy assessments. Self-reported work-related
symptoms are relatively sensitive indicators in the
diagnosis of occupational asthma but the specificity is
low. In approximately one third of the included studies,
self-reported asthma symptoms or physician-reported
asthma were used as the only diagnostic approach. Lung
function, allergy testing and the diagnostic gold standards,
serial spirometric or peak flow measurements (sPFT) or
specific inhalation challenges, were each applied in only
about one third to half of studies.
The level of evidence for single agents also depends on
the absolute number of publications. Agents for which
the research activity is higher may obtain higher levels in
our rating system and, conversely, an absence or a low
evidence grade of an occupational agent (e.g. in studies
without SIC or lung function testing) does not necessarily
exclude its potential for causing occupational asthma.
It is evident that more work is needed to consolidate the
gaps, such as the study of potential asthma-inducing
agents which have not or only rarely been investigated so
far. This current overview provides a basis for such
supplementary work and for surveillance programs of
endangered workers. The latter may facilitate early diagnosis
and the application of appropriate secondary preventive
measures, leading to a significant reduction of asthma
from identified causative exposure in the workplace.Competing interests
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